Company intelligence / Profile preview
Causeway Therapeutics
Glasgow, Scotland, United Kingdomcausewaytx.com ↗
- Ownership
- Private
- Employees
- ~9
- Development stage
- Phase 2
01
Overview
TenoMiR, a one-time injectable miR29a mimic, has shown significant improvement in tendon healing in preclinical models. It is currently being evaluated in a Phase II trial for tennis elbow/lateral epicondylitis. There are no approved therapies for tendinopathy; TenoMiR aims to address this unmet need by restoring normal tendon structure through microRNA modulation. Early data indicate potential to improve function and reduce pain.
- Therapeutic areas
- CardiovascularDermatologyRheumatology
- Modalities
- microRNA therapeutics (miRNA)nucleic acid therapies
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
Scottish Enterprise / Scottish Investment Bank – co-investors/supporters of early development and commercialization efforts
Beyond the preview
Go deeper on Causeway Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Causeway Therapeutics.